Literature DB >> 17826797

Endogenous or exogenous oligodendrocytes for remyelination.

W F Blakemore1, K-A Irvine.   

Abstract

The relative merits of endogenous and exogenous oligodendrocyte progenitor cells (OPCs) for remyelination are compared in terms of their ability to repopulate OPC-depleted tissue and generate remyelinating oligodendrocytes. Exogenous neonatal OPCs can repopulate OPC-depleted tissue 5-10 times faster than endogenous cells and as a result are capable of more extensive remyelination. Both endogenous and exogenous cells will only repopulate normal tissue if there is extensive depletion of the local OPC population and both show reduced ability to generate remyelinating cells in the absence of acute inflammation. When endogenous OPCs are depleted by X-irradiation during cuprizone intoxication, where there is a combination of astrocytosis and acute demyelination, endogenous but not exogenous embryo-derived OPCs fail to repopulate the OPC-depleted cortex.

Entities:  

Mesh:

Year:  2007        PMID: 17826797     DOI: 10.1016/j.jns.2007.08.004

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

Review 1.  Cell replacement therapies to promote remyelination in a viral model of demyelination.

Authors:  Emanuele Tirotta; Kevin S Carbajal; Chris S Schaumburg; Lucia Whitman; Thomas E Lane
Journal:  J Neuroimmunol       Date:  2010-06-02       Impact factor: 3.478

Review 2.  Cell-based reparative therapies for multiple sclerosis.

Authors:  Tamir Ben-Hur; Nina Fainstein; Yossi Nishri
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

Review 3.  Brief review: Can modulating DNA methylation state help the clinical application of oligodendrocyte precursor cells as a source of stem cell therapy?

Authors:  Naohiro Egawa; Kelly K Chung; Ryosuke Takahashi; Eng H Lo; Haruhisa Inoue; Ken Arai
Journal:  Brain Res       Date:  2019-08-13       Impact factor: 3.252

4.  Clinical relevance of serum aquaporin-4 antibody levels in neuromyelitis optica.

Authors:  Noriko Isobe; Tomomi Yonekawa; Takuya Matsushita; Katsuhisa Masaki; Satoshi Yoshimura; Jakub Fichna; Shu Chen; Jadwiga Furmaniak; Bernard Rees Smith; Jun-Ichi Kira
Journal:  Neurochem Res       Date:  2013-03-02       Impact factor: 3.996

5.  The Biology of Persistent Infection: Inflammation and Demyelination following Murine Coronavirus Infection of the Central Nervous System.

Authors:  Martin P Hosking; Thomas E Lane
Journal:  Curr Immunol Rev       Date:  2009-05-04

Review 6.  Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.

Authors:  Anna J Khalaj; Jonathan Hasselmann; Catherine Augello; Spencer Moore; Seema K Tiwari-Woodruff
Journal:  J Steroid Biochem Mol Biol       Date:  2016-01-14       Impact factor: 4.292

Review 7.  Paving the axonal highway: from stem cells to myelin repair.

Authors:  Raniero L Peru; Nicole Mandrycky; Brahim Nait-Oumesmar; Q Richard Lu
Journal:  Stem Cell Rev       Date:  2008-12       Impact factor: 5.739

8.  Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS.

Authors:  Jigisha R Patel; Jessica L Williams; Megan M Muccigrosso; Laindy Liu; Tao Sun; Joshua B Rubin; Robyn S Klein
Journal:  Acta Neuropathol       Date:  2012-08-30       Impact factor: 17.088

9.  Inefficient clearance of myelin debris by microglia impairs remyelinating processes.

Authors:  Antoine Lampron; Antoine Larochelle; Nathalie Laflamme; Paul Préfontaine; Marie-Michèle Plante; Maria Gabriela Sánchez; V Wee Yong; Peter K Stys; Marie-Ève Tremblay; Serge Rivest
Journal:  J Exp Med       Date:  2015-03-16       Impact factor: 14.307

10.  Effects of murine and human bone marrow-derived mesenchymal stem cells on cuprizone induced demyelination.

Authors:  Jasmin Nessler; Karelle Bénardais; Viktoria Gudi; Andrea Hoffmann; Laura Salinas Tejedor; Stefanie Janßen; Chittappen Kandiyil Prajeeth; Wolfgang Baumgärtner; Annemieke Kavelaars; Cobi J Heijnen; Cindy van Velthoven; Florian Hansmann; Thomas Skripuletz; Martin Stangel
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.